Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
We also demonstrated that sonic hedgehog (Shh) expression, in cooperation with loss of the Trp53 and Ink4a/Arf tumor suppressor loci, was sufficient to initiate the formation of early pancreatic lesions.
|
17611415 |
2007 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study examined genetic variants in the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene that encodes the p16(INK4a) and p14(ARF) tumor suppressors, and the isocitrate dehydrogenase 1 (IDH1) gene as potential markers of survival for 40 individuals with NDTMM GBMs (telomerase negative and ALT negative by standard assays), 50 individuals with telomerase, and 17 individuals with ALT positive tumors.
|
22046342 |
2011 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
The INK4a/ARF tumor suppressor gene locus is one of the major targets of Bmi-1.
|
24552182 |
2014 |
Acute respiratory failure
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The INK4a-ARF (CDKN2A) locus on chromosome 9p21 encodes two tumour suppressor proteins, p16(INK4a) and p14(ARF), which act as upstream regulators of the Rb-CDK4 and p53 pathways.
|
12375265 |
2002 |
Acute respiratory failure
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Together, these results indicate that modest increases in the activity of the Ink4a/Arf tumor suppressor result in a beneficial cancer-resistant phenotype without affecting normal viability or aging.
|
15520276 |
2004 |
Acute respiratory failure
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Deletion of the INK4a/ARF tumor suppressor locus and trisomy 3 also occurred almost exclusively in ABC DLBCLs and was associated with inferior outcome within this subtype.
|
18765795 |
2008 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, whereas germ-line mutations of PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 are not common events in familial glioma, outside of familial cancer syndromes, point mutations of p53 and hemizygous deletions and other rearrangements of the p16(INK4A)/p14(ARF) tumor suppressor region may account for a subset of familial glioma cases.
|
10797439 |
2000 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Overexpression of the polycomb group gene Bmi1 promotes cell proliferation and induces leukaemia through repression of Cdkn2a (also known as ink4a/Arf) tumour suppressors.
|
15029199 |
2004 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
The p16(INK4a) and p14(ARF) tumor suppressor genes (TSGs) are encoded within the CDKN2A locus on chromosome 9p21 and function as cell cycle regulatory proteins in the p53 and RB pathways.
|
15140233 |
2004 |
Acute respiratory failure
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Expression of the ARF tumor suppressor is regulated by runt-related X1, suggesting that the inv(16) fusion protein (IFP) may repress ARF expression.
|
16199529 |
2005 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
These data suggest that expression of the Ink4a/Arf tumor suppressor locus is a robust biomarker, and possible effector, of mammalian aging.
|
15520862 |
2004 |
Acute respiratory failure
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The INK4a-ARF (CDKN2A) locus, located on chromosome 9p21, encodes two functionally distinct tumor suppressor genes, p14(ARF) and p16(INK4a), that play active roles in the p53 and Rb tumor suppressive pathways, respectively.
|
12189502 |
2002 |
Acute respiratory failure
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Chromobox 7 (CBX7) is a Polycomb family protein that extends the lifespan of normal human cells via downregulating the expression of INK4a/ARF tumor suppressor locus.
|
20723236 |
2010 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
The locus harbors the CDKN2A/ARF tumor suppressor gene, which encodes two cell cycle regulatory proteins cyclin dependent kinase 2A (p16(INK4a)) and alternate reading frame (p14(ARF)).
|
12538475 |
2003 |
Acute respiratory failure
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We report here that experimental induction of E2a-Pbx1 enhances expression of BMI-1, a lymphoid oncogene whose product functions as a transcriptional repressor of the INK4A-ARF tumor suppressor locus.
|
14536079 |
2003 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although the importance of the ARF tumor suppressor in p53 regulation is well established, numerous studies indicate that ARF also suppresses cell growth in a p53/Mdm2-independent manner.
|
15989956 |
2005 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Importantly, these data establish that the ARF-E2F-1 pathway is an extension of the p53-mdm2-ARF tumor suppressor network and is unlikely to constitute a p53-independent pathway for ARF function.
|
17630509 |
2007 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
The INK4a/ARF tumor suppressor: one gene--two products--two pathways.
|
9757829 |
1998 |
Acute respiratory failure
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Here we show that the Wnt-effector Tcf1 is recruited to and triggers transcription of the Ink4/Arf tumor suppressor locus.
|
28346462 |
2017 |
Acute respiratory failure
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Overall, somatic mutation of the INK4a/ARF tumor suppressor locus, resulting in functionally deficient p16 and possibly p14(ARF) proteins, seems to be a prevalent event in the development of SCCHN.Mol.Carcinog.30:26-36, 2001.
|
11255261 |
2001 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Modeling INK4/ARF tumor suppression in the mouse.
|
17311533 |
2007 |
Acute respiratory failure
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The cytotoxicity of 5-aza-2'-deoxycytidine (DAC) has been linked to demethylation of the INK4a/ARF tumor suppressor gene locus in various cell systems, but the causality of this association remains unproven.
|
19372550 |
2009 |
Acute respiratory failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
In Europe and North America, between 8-14% of melanoma patients have a family history of the disease, and a subset of these individuals possess germline mutations in the CDKN2A gene, which encodes the p16(INK4A) and p14(ARF) tumor suppressors.
|
17713569 |
2008 |